skip to navigation skip to content

Healx

Strategic Business Growth 2020 – applications are open

The Strategic Business Growth programme from the Cambridge Judge Entrepreneurship Centre recognises the challenges that businesses face when scaling up. We are recruiting the next cohort for February 2020. It is designed to support those companies that are determined to…

Read more

Strategic Business Growth applications open

Movers and shakers

Five women associated with Cambridge Judge Business School are named in BioBeat report on 50 top women leaders and innovators in biotech. Five women associated with Cambridge Judge Business School are included in the sixth annual 50 Movers and Shakers…

Read more

Movers and shakers, female scientists using a centrifuge.

Award-winning ventures

Several companies associated with Cambridge Judge Business School are honoured at the Cambridge Independent Science and Technology Awards. Several companies associated with Cambridge Judge Business School were honoured at the 2019 Cambridge Independent Science and Technology Awards announced on 30…

Read more

Image of gold stars

Funding for rare diseases startup

Healx, a company that seeks breakthroughs for rare diseases through artificial intelligence, said it had secured $56 million in Series B financing, led by venture capital firm Atomico and joined by Intel Capital, Global Brain and btov Partners. All previous investors…

Read more

Funding for rare diseases startup

The Telegraph: Rare disease drug firm Healx raises $56 million

Healx, a startup that seeks breakthroughs for rare diseases through artificial intelligence, secured $56 million in Series B financing, led by venture capital firm Atomico. The funding will be used to develop Healx’s therapeutic pipeline and to launch its global…

Read more

EU startups: 10 Cambridge-based startups to look out for in 2019 and beyond

Two ventures connected to Cambridge Judge Business School are on the list of Cambridge startups “to look out for” in 2019. Healx is seeking breakthroughs for rare diseases through artificial intelligence, and Entomics aims to convert food waste into energy.…

Read more

The Independent: Meet the drug hunters: the scientists determined to cure rare diseases

An interview with David Brown and Tim Guilliams, co-founders of the Healx startup that was on the Accelerate Cambridge programme run by the Cambridge Judge Entrepreneurship Centre. The company is looking to find new therapeutic solutions to cure patients with…

Read more

The Times: Maserati 100: Meet the innovators

Tim Guilliams, co-founder of the Healx startup, is on the Maserati 100 list that celebrates the “positive impact entrepreneurs have on the economy and society as a whole.” Healx, previously on the Accelerate Cambridge programme run by the Cambridge Judge…

Read more

Business Weekly: Seven Cambridge companies in UK gazelles hot 100 list

Equity crowdfunder SyndicateRoom have created a list of Britain’s fastest-growing companies. The Top 100 list highlights some Cambridge-based companies, including two startups connected to Cambridge Judge Business School. Healx, which researches the use of existing medicines to cure rare diseases,…

Read more

Forbes: How one startup is using AI to find cures for 100 rare diseases by 2025

Battling rare diseases is one of the most prevailing challenges of our time. According to Global Genes, scientists have uncovered around 7,000 different types, all of which affect 350 million people worldwide. However, because rare diseases are so severe and…

Read more

New funding for Healx

Archives